Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 30,000 shares at $17.45 ($523,500)
  7. 4 Open-market buy Director bought 18,477 shares at an average $16.67 ($307,928)
  8. 4 Exercise or conversion Director acquired 1,000 shares (option exercise)
  9. 4 Shares withheld for taxes President and CEO gave up 57,268 shares (to pay taxes)
  10. 4 Exercise or conversion Director acquired 9,284 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes Director gave up 7,077 shares (to pay taxes)
  17. 4 Shares withheld for taxes Director gave up 5,139 shares (to pay taxes)
  18. 4 Open-market buy Director bought 88,841 shares at an average $25.81 ($2,292,823)
  19. 5 Insider Annual Insider Trading Report
  20. 5 Insider Annual Insider Trading Report

Page 4 of 30 · 591 filings